Skip to main content
. 2020 Jul 1;75(11):2775–2793. doi: 10.1111/all.14439

Table 2.

Hypersensitivity reactions due to drugs with antiviral properties investigated for the treatment of COVID‐19 in clinical trials or in vitro studies

Drug groups Drugs Purpose of use in COVID‐19 Hypersensitivity reactions In vivo tests in IHRs In vivo tests in NIHRs In vitro tests for IHRs In vitro tests for NIHRs Desensitization
Antiviral drugs Favipiravir Viral pneumonia None
Lopinavir/Ritonavir AGEP 61 , MPE 60
Darunavir/Ritonavir

MPE 66

Vesiculobullous lesions 48 , 64

DNIHR 66 , 67
Umifenovir (Arbidol) None
Ribavirin

Pruritus 46 , 55

Eczema 46 , 53 , 54 , 55

Urticaria 58

MPE 56

DPT 56 LTT 57 DNIHR 58 , 59
Remdesivir (GS‐5734) MPE 51
Oseltamivir

Anaphylaxis 68

SJS/TEN 46 , TEN 47

SPT 68 LTT 50
Immunomodulatory drugs Azithromycine

MPE 73 , 74 , ACD 75 , 76 , FDE 77

AGEP 78 , DRESS 79

SJS 80 , 81

Anaphylaxis 72

Urticaria 71

Leukocytoclastic vasculitis 82

Hypersensitivity myocarditis 83

SPT 84 , 85

IDT 84 , 85

DPT 87

PT 75

DPT 87

DIHR 88

Hydroxychloroquine / Chloroquine

MPE 90 , AGEP 92 , 103

DRESS 93 , 94 , 95

Erythema multiforme 96

Bullous erythema 97

SJS/TEN 99 , 100

Photoallergic dermatitis 101

ACD 102

Anaphylaxis 109 , 110

SPT 109

PT 96 , 98 , 103

DPT 90

DNIHR 104 , 105 , 106 , 107 , 108

DIHR 109 , 110

Auranofin None
Interferons

Local reaction 116

Urticaria 119 , 122 , 123

Eczema 119 , FDE 120 , MPE 119

Anaphylaxis 124 , 125

SPT 122 , 123 , 124

DPT 125

IDT 119 , 126

PT 119

DIHR 123

DNIHR 119 , 127

Nitazoxanide None
Ivermectin FDE 129 , DRESS 130 , SJS 131 , TEN 132

Abbreviations: ACD, Acute contact dermatitis; AGEP, Acute generalized exanthematous pustulosis; BAT, Basophil activation test; DIHR, Desensitization for immediate hypersensitivity reactions; DNIHR, Desensitization for nonimmediate hypersensitivity reactions;DPT, Drug provocation test; DRESS, Drug‐related eosinophilia systemic symptoms; FDE, Fixed drug eruption; IDT, Intradermal test; IHR, Immediate hypersensitivity reaction; LTT, Lymphocyte transformation test; MPE, Maculopapular eruption; NIHR, Nonimmediate hypersensitivity reaction; PT, Patch test; SJS, Stevens Johnson syndrome; SPT, Skin prick test; ST, Skin test; TEN, Toxic epidermal necrolysis.